NCT06860035 Dementia Caregivers' Link to Assistance and Resources
| NCT ID | NCT06860035 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Visiting Nurse Service of New York |
| Condition | Alzheimer Disease or Associated Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-05-05 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if the Dementia Caregivers' Link to Assistance and Resources (DECLARE) program can improve support of, and engagement with, caregivers of home health patients with dementia. DECLARE includes a caregiver self-assessment that is reported in the home health patient record, and increased access to social work for cases including dementia caregivers. The main questions we aim to answer are: * Will most caregivers who are offered the chance to complete an assessment choose to do so? * Will clinicians report that the assessment information was useful? * Will the rate of social work access increase for cases with patients with dementia who have involved family caregivers? Researchers will compare DECLARE to usual care to see if taking part in the program increases caregiver self-efficacy and access to social work. Participants will: * Answer a short series of assessment questions and questions about their caregiving experiences at the beginning of the home health episode. * Receive a social work visit from a Licensed Social Worker trained in dementia care. * Answer a series of follow-up questions about their caregiving experiences at the end of the home health episode.
Eligibility Criteria
Inclusion Criteria: * Individual must be listed as the caregiver of record for a patient receiving home health care from the partner home health agency and have a phone number on file; the patient must meet the inclusion criteria listed below. * Home health patient (care recipient) must have a documented dementia diagnosis on the home health assessment, be 65 years or older, and have Traditional Medicare or Medicare Advantage as their primary payer for the home health episode. Exclusion Criteria: * Caregivers are excluded if they are unable to communicate in English.
Contact & Investigator
Julia G Burgdorf, PhD
PRINCIPAL INVESTIGATOR
Center for Home Care Policy & Research, VNS Health
Frequently Asked Questions
Who can join the NCT06860035 clinical trial?
This trial is open to participants of all sexes, studying Alzheimer Disease or Associated Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06860035 currently recruiting?
Yes, NCT06860035 is actively recruiting participants. Contact the research team at julia.burgdorf@vnshealth.org for enrollment information.
Where is the NCT06860035 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06860035 clinical trial?
NCT06860035 is sponsored by Visiting Nurse Service of New York. The principal investigator is Julia G Burgdorf, PhD at Center for Home Care Policy & Research, VNS Health. The trial plans to enroll 200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.